Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 87391)

Published in J Clin Microbiol on September 01, 2000

Authors

M H Mayrand1, F Coutlée, C Hankins, N Lapointe, P Forest, M de Ladurantaye, M Roger

Author Affiliations

1: Départements de Microbiologie et de Pédiatrie, Université de Montréal, Montreal, Quebec, Canada.

Articles cited by this

Basic local alignment search tool. J Mol Biol (1990) 659.07

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86

Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med (1998) 11.61

Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis (1994) 7.00

Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA (1991) 6.83

Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst (1995) 6.24

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature (1998) 6.16

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96

Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis (1994) 4.89

The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer (1995) 3.29

Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol (1997) 2.40

Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer (1996) 2.30

The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol (1993) 2.27

Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol (1995) 2.13

Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst (1997) 2.06

Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol (1999) 1.95

Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis (1995) 1.94

Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol (1992) 1.80

Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus. Sex Transm Dis (1997) 1.71

New epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst (1995) 1.71

Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group. CMAJ (1999) 1.63

Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction. The Canadian Women's HIV Study Group. J Med Virol (1997) 1.60

Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol (1991) 1.57

Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol (1997) 1.41

Human papillomaviruses and cervical cancer. Adv Cancer Res (1997) 1.32

Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol (1995) 1.25

Participation in clinical trials among women living with HIV in Canada. Canadian Women's HIV Study Group. CMAJ (1998) 1.14

Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis (1995) 1.14

Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol (1996) 1.14

The future of HPV testing in clinical laboratories and applied virology research. Clin Diagn Virol (1997) 1.12

Genotypes and sequence variants of human papillomavirus DNAs from human immunodeficiency virus type 1-infected women with cervical intraepithelial neoplasia. J Infect Dis (1992) 1.05

Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. J Infect Dis (1993) 1.02

Genotyping human papillomavirus type 16 isolates from persistently infected promiscuous individuals and cervical neoplasia patients. J Clin Microbiol (1995) 1.01

Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res (1998) 0.93

Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection. J Natl Cancer Inst (1994) 0.88

Sequence variation in the noncoding region of human papillomavirus type 16 detected by single-strand conformation polymorphism analysis. J Infect Dis (1993) 0.88

Low-stringency single specific primer PCR, DNA sequencing and single-strand conformation polymorphism of PCR products for identification of genetic variants of human papillomavirus type 16. J Virol Methods (1995) 0.79

Articles by these authors

Improved amplification of genital human papillomaviruses. J Clin Microbiol (2000) 11.50

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med (1999) 6.13

HIV infection among Quebec women giving birth to live infants. CMAJ (1990) 3.38

Excision and repair of mismatched base pairs in transformation of Streptococcus pneumoniae. Mol Gen Genet (1980) 2.33

Evidence for conversion of heteroduplex transforming DNAs to homoduplexes by recipient pneumococcal cells (DNA strand resolution-DNA repair-bacterial transformation-genetic recombination). Proc Natl Acad Sci U S A (1972) 2.17

Diagnosis of vertical HIV-1 transmission using the polymerase chain reaction and dried blood spot specimens. J Acquir Immune Defic Syndr (1992) 1.78

Risk factors in pediatric AIDS. Can Med Assoc J (1985) 1.77

Rapid screening for early detection of mother-to-child transmission of human immunodeficiency virus type 1. J Clin Microbiol (1994) 1.68

Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group. CMAJ (1999) 1.63

Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction. The Canadian Women's HIV Study Group. J Med Virol (1997) 1.60

Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. The Canadian Women's HIV study group. J Clin Microbiol (1999) 1.58

Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts. J Biol Chem (2001) 1.54

Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A (2000) 1.51

Needle exchange: panacea or problem? CMAJ (1997) 1.48

Transplacental transmission of HTLV-III virus. N Engl J Med (1985) 1.47

Spin correlations in the paramagnetic phase and ring exchange in La2CuO4. Phys Rev Lett (2005) 1.40

Fractionation of denatured pneumococcal DNA: evidence for resolution of complementary strands. J Mol Biol (1966) 1.37

Evaluation of a vanA-specific PCR assay for detection of vancomycin-resistant Enterococcus faecium during a hospital outbreak. J Clin Microbiol (1999) 1.33

Confronting HIV infection in prisons. CMAJ (1994) 1.32

Separation of native and denatured fractions from partially denatured pneumococcal DNA. J Mol Biol (1966) 1.32

Ethical considerations related to the provision of care and treatment in vaccine trials. Vaccine (2007) 1.30

Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus (1999) 1.29

Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the telecom study. J Clin Endocrinol Metab (1993) 1.27

Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study. Osteoporos Int (2007) 1.26

Dried blood spots collected on filter paper: an international resource for the diagnosis and genetic characterization of human immunodeficiency virus type-1. Mem Inst Oswaldo Cruz (1997) 1.26

Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection. J Immunol (2003) 1.25

Genetic control of some metabolic modifications during the sporulation of Saccharomyces cerevisiae Hansen. J Gen Microbiol (1974) 1.23

Chromatographic resolution of complementary strands of denatured Pneumococcal DNA. Proc Natl Acad Sci U S A (1968) 1.23

Acquired (or congenital) immunodeficiency syndrome in infants born of Haitian mothers. N Engl J Med (1983) 1.15

Participation in clinical trials among women living with HIV in Canada. Canadian Women's HIV Study Group. CMAJ (1998) 1.14

Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS (1996) 1.13

An important proportion of genital samples submitted for Chlamydia trachomatis detection by PCR contain small amounts of cellular DNA as measured by beta-globin gene amplification. J Clin Microbiol (2000) 1.11

Mismatch excision and possible polarity effects result in preferred deoxyribonucleic acid strand of integration in pneumococcal transformation. J Bacteriol (1977) 1.11

The influence of aging on plasma sex hormones in men: the Telecom Study. Am J Epidemiol (1992) 1.10

Prevalence of HIV infection among pregnant women in Newfoundland. CMAJ (1996) 1.10

The role of prisons in the HIV epidemic among female injecting drug users. AIDS Care (2002) 1.09

Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty. J Clin Endocrinol Metab (1999) 1.08

Sexuality in Montreal women living with HIV. AIDS Care (1997) 1.08

Severe exacerbation of systemic lupus erythematosus after hepatitis B vaccination and importance of pneumococcal vaccination in patients with autosplenectomy: comment on the article by Battafarano et al. Arthritis Rheum (1999) 1.06

Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format. J Clin Microbiol (2001) 1.05

Thymic epithelium in AIDS. An immunohistologic study. Am J Pathol (1986) 1.05

Unusual prevalence of Epstein-Barr virus early antigen (EBV-EA) antibodies in ataxia telangiectasia. J Immunol (1977) 1.04

Giant-cell pneumonia caused by parainfluenza virus. J Pediatr (1979) 1.04

HIV-1 infection in a medium security prison for women--Quebec. Can Dis Wkly Rep (1989) 1.04

Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study. Diabetologia (1992) 1.02

Topographical organization of the projections from physiologically identified areas of the motor cortex to the striatum in the rat. Neurosci Res (1992) 1.00

Dopamine D3 receptor stimulation promotes the proliferation of cells derived from the post-natal subventricular zone. J Neurochem (2004) 1.00

Interpretation of plasma luteinizing hormone assay for the collection of mature oocytes from women: definition of a luteinizing hormone surge-initiating rise. Fertil Steril (1981) 0.99

Anti-müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development. J Clin Endocrinol Metab (1993) 0.99

Discordance between primer pairs in the polymerase chain reaction for detection of human immunodeficiency virus type 1: a role for taq polymerase inhibitors. J Infect Dis (1991) 0.99

Squamous anal cancer: patient characteristics and HPV type distribution. Cancer Epidemiol (2013) 0.99

Suppression of thermal conductivity by rattling modes in thermoelectric sodium cobaltate. Nat Mater (2013) 0.98

Reduced post-natal rise of testosterone in plasma of cryptorchid infants. Acta Endocrinol (Copenh) (1978) 0.98

Unintended subcutaneous and intramuscular injection by drug users. CMAJ (2000) 0.97

Features of insulin-resistance syndrome in men from French Caribbean Islands. The Telecom Study. Diabetes (1992) 0.96

Ventral temporal cortex in the rat: connections of secondary auditory areas Te2 and Te3. J Comp Neurol (1990) 0.96

Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition. J Clin Endocrinol Metab (1993) 0.94

Improved detection of HIV-1 envelope sequences using optimized PCR and inosine-substituted primers. Mol Cell Probes (1991) 0.94

Thyroid antigen-antibody nephritis. Clin Immunol Immunopathol (1976) 0.94

Subacute sclerosing panencephalitis. Elevated Epstein-Barr virus antibody titers and failure of amantadine therapy. J Neurol Sci (1974) 0.94

Detection of polymerase chain reaction-amplified human immunodeficiency virus type 1 proviral DNA with a digoxigenin-labeled RNA probe and an enzyme-linked immunoassay. J Clin Microbiol (1993) 0.93

Delayed appearance of plasmatic chorionic gonadotropin in pregnancies after in vitro fertilization and embryo transfer. Fertil Steril (1984) 0.93

HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group. Hum Immunol (2000) 0.93

Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics. J Pediatr Endocrinol Metab (2000) 0.93

Clinical evaluation of Amplicor HIV-1 test for detection of human immunodeficiency virus type 1 proviral DNA in peripheral blood mononuclear cells. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.92

Age-related decline of plasma bioavailable testosterone in adult men. J Steroid Biochem (1990) 0.91

Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes (2000) 0.91

Socioeconomic geographical links to human immunodeficiency virus seroprevalence among childbearing women in Montreal, 1989-1993. Int J Epidemiol (1998) 0.91

Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone. Maturitas (1993) 0.91

Unusual prevalence of antibodies to Epstein-Barr virus early antigen in ataxia telangiectasia. Lancet (1977) 0.91

Pathogenicity of HIV in lymphatic organs of patients with AIDS. J Pathol (1987) 0.91

Epidemiology of HIV infection. Can J Public Health (1989) 0.91

Plasma gonadotropin and testosterone values in infants with cryptorchidism. J Pediatr (1980) 0.91

5-azacytidine and 5-azadeoxycytidine inhibit human immunodeficiency virus type 1 replication in vitro. Antimicrob Agents Chemother (1990) 0.90

Continuous elemental enteral alimentation in the treatment of children and adolescents with Crohn's disease. JPEN J Parenter Enteral Nutr (1982) 0.90

Endocrine aspects and tumoral markers in intracranial germinoma: an attempt to delineate the diagnostic procedure in 14 patients. J Pediatr (1982) 0.90

Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects. J Clin Endocrinol Metab (2000) 0.90

Giant cell pneumonia due to respiratory syncytial virus. Occurrence in severe combined immunodeficiency syndrome. Arch Pathol Lab Med (1984) 0.90

Sexual behavior and pregnancy outcome in HIV-infected women. Canadian Women's HIV Study Group. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.89

Main inhibitor of follicle stimulating hormone in the luteal-follicular transition: inhibin A, oestradiol, or inhibin B? Hum Reprod (1999) 0.89

Falsely elevated serum thyrotropin (TSH) in newborn infants: transfer from mothers to infants of a factor interfering in the TSH radioimmunoassay. J Clin Endocrinol Metab (1981) 0.89

IgE in ataxia-telangiectasia and family members. Lancet (1970) 0.88

Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type I diabetes in 220 juvenile first-degree relatives of diabetic patients. Diabetes Care (1991) 0.88

Successful implementation of a national HLA-B*5701 genetic testing service in Canada. Tissue Antigens (2009) 0.87

Analysis of human papillomavirus in schneiderian papillomas as compared to chronic sinusitis and normal nasal mucosa. J Otolaryngol (2001) 0.87

HLA-Bw35 and prognosis in adult Still's disease. Arthritis Rheum (1981) 0.87

Differences in immunoregulatory cytokine expression patterns in the systemic and genital tract compartments of HIV-1-infected commercial sex workers in Benin. Mucosal Immunol (2008) 0.87

Osteomalacia cured by surgery. Eur J Intern Med (2002) 0.87

17 alpha-hydroxylase deficiency syndrome associated with bilateral streak gonads and impaired development of Müllerian ducts derivatives. Report of a case. Acta Endocrinol (Copenh) (1982) 0.86

Correlation of pituitary and testicular responses to stimulation tests in cryptorchid children. Acta Endocrinol (Copenh) (1977) 0.86

Immunological comparison of muscle actins from mammal, bird and fish: a quantitative approach. FEBS Lett (1979) 0.86